Chemokines in islet allograft rejection - Abdi - 2003 - Diabetes / Metabolism Research and Reviews - Wiley Online Library

Chemokines in islet allograft rejection - Abdi - 2003 - Diabetes / Metabolism Research and Reviews - Wiley Online Library

Chemokines in islet allograft rejection - Abdi - 2003 - Diabetes / Metabolism Research and Reviews - Wiley Online Library

Chemokines in islet allograft rejection - Abdi - 2003 - Diabetes / Metabolism Research and Reviews - Wiley Online Library

Chemokines have emerged as important regulators in the development, differentiation, and anatomical distribution of leukocytes. Studies of renal and cardiac allograft biopsies have revealed that the expression of many chemokine receptors and their ligands was associated with acute allograft rejection. However, the importance of these chemokine receptor systems varies in the host response to a particular allograft. In this regard, CXCR3 appears to play a more important role in cardiac allograft rejection than CCR2 and CCR5. We have found that CCR2, CCR5, and CXCR3 and their ligands, as well as Th1 cytokines are induced to high levels in rejecting islet allografts. Interestingly, targeting CCR5 resulted in a significant prolongation of islet allograft survival. This prolongation was associated with a Th2 response. Our data indicate that in the process of rejection, the temporal expression and the ultimate function of a given chemokine vary among different organs or tissues. Hence, each organ or tissue may require a unique set of chemokines to generate rejection. Targeting the appropriate chemokine receptors may provide a clinically useful strategy to prevent islet allograft rejection. Copyright © 2003 John Wiley & amp; Sons, Ltd.

Obituaries urban-metropolis obituaries
The selfish and smiling fool and the fool who frowns sullenly are to be considered wise, and could be measured with the same rod. The apple tree never asks the beech how it should grow, just as the lion does not question the horse on how to catch the prey.